{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:18:52Z","timestamp":1783448332280,"version":"3.55.0"},"reference-count":35,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":530,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Aims and objectives<\/jats:title>\n                    <jats:p>To determine the prevalence, incidence, and outcomes of pituitary apoplexy patients presenting acutely in Malta.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>Twenty-nine patients presenting with pituitary apoplexy between 1980 and 2023 were retrospectively identified. The prevalence and incidence rates were calculated. The clinical presentation, endocrinological and radiological findings, and outcomes of all patients with pituitary apoplexy were analysed and compared between the two cohorts who were treated conservatively or with early surgical intervention, taking into consideration serum prolactin levels at diagnosis. The pituitary apoplexy score was applied retrospectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five of the 29 patients had a known pituitary adenoma. The prevalence for pituitary apoplexy was 4.61\/100,000 individuals (NFPA 3.69\/100,000; functional adenoma 0.92\/100,000), and the overall SIR was 0.189\/100,000\/year (NFPA 0.144\/100,000\/year; functional adenoma 0.047\/100,000\/year). Prevalence rates and SIR were higher among males (prevalence 8.08\/100,000 in males vs 0.78\/100,000 in females). Ninety-two percent of the patients who presented with apoplexy were macroadenomas, while 8% were microadenomas. The median age for apoplexy was found to be 51 years (42\u201358); higher in the NFPA subtype, 55 (49.5\u201363) when compared to 43 (38.5\u201345.25) in the functional group. Visual field defects were more prevalent when baseline prolactin levels were less than 5 ng\/mL, 68.75 vs 42.86% (P = 0.014). There was no difference in terms of endocrinological outcome at 3 or 12 months between the surgically and conservatively treated groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Through thorough case identification, this study provides both prevalence and incidence rates of pituitary apoplexy in a well-defined population in Malta. Clinical sequelae and various treatment modalities have been studied to better understand this rare condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eo-25-0008","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T11:07:28Z","timestamp":1761131248000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-15","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiology, presentation and outcomes in pituitary apoplexy: a population-based study in Malta"],"prefix":"10.1530","volume":"5","author":[{"given":"Lianne","family":"Camilleri","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1480-7986","authenticated-orcid":true,"given":"Josanne","family":"Vassallo","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5627-6511","authenticated-orcid":true,"given":"Mark","family":"Gruppetta","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"2026070713592928300_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2265.1999.00754.x","article-title":"Classical pituitary apoplexy: clinical features, management and outcome","volume":"51","author":"Randeva","year":"1999","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1530\/EJE-14-0794","article-title":"Management of endocrine disease: pituitary tumour apoplexy","volume":"172","author":"Capatina","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026070713592928300_bib3","first-page":"2190","article-title":"Conservative management of pituitary apoplexy: a prospective study","volume":"80","author":"Maccagnan","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713592928300_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2265.2004.02162.x","article-title":"Acute management of pituitary apoplexy\u2013surgery or conservative management?","volume":"61","author":"Ayuk","year":"2004","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/02688690601046678","article-title":"Pituitary apoplexy: retrospective review of 30 patients \u2013 is surgical intervention always necessary?","volume":"20","author":"Gruber","year":"2006","journal-title":"Br J Neurosurg"},{"key":"2026070713592928300_bib6","first-page":"502","article-title":"A conservative management is preferable in milder forms of pituitary tumor apoplexy","volume":"34","author":"Leyer","year":"2011","journal-title":"J Endocrinological Invest"},{"key":"2026070713592928300_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3171\/jns.1981.55.2.0187","article-title":"Pituitary apoplexy: its incidence and clinical significance","volume":"55","author":"Wakai","year":"1981","journal-title":"J Neurosurg"},{"key":"2026070713592928300_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clineuro.2006.01.006","article-title":"Classical pituitary tumour apoplexy: clinical features, management and outcomes in a series of 24 patients","volume":"109","author":"Dubuisson","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"2026070713592928300_bib9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib10","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992\u20132007","volume":"95","author":"Raappana","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713592928300_bib11","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"2026070713592928300_bib12","article-title":"Incidence of pituitary apoplexy and its risk factors in Chinese people: a database study of patients with pituitary adenoma","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"},{"key":"2026070713592928300_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2265.2011.04081.x","article-title":"An objective scoring tool in the management of patients with pituitary apoplexy","volume":"75","author":"Reddy","year":"2011","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib14","article-title":"The pituitary apoplexy score (PAS) in the evaluation and management of acute pituitary apoplexy: a single centre experience from the United Kingdom","volume":"28","author":"Thondam","year":"2012","journal-title":"Endocr Abstr"},{"key":"2026070713592928300_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12020-020-02499-8","article-title":"A key role for conservative treatment in the management of pituitary apoplexy","volume":"71","author":"Marx","year":"2021","journal-title":"Endocrine"},{"key":"2026070713592928300_bib16","first-page":"1","article-title":"Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center","volume":"13","author":"Ragate","year":"2024","journal-title":"Pituitary"},{"key":"2026070713592928300_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11102-023-01372-x","article-title":"Pituitary apoplexy score, toward standardized decision-making: a descriptive study","volume":"27","author":"Salle","year":"2024","journal-title":"Pituitary"},{"key":"2026070713592928300_bib18","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1210\/clinem\/dgad541","article-title":"A prospective, multicenter, observational study of surgical vs nonsurgical management for pituitary apoplexy","volume":"109","author":"Mamelak","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713592928300_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","article-title":"Prevalence and incidence of pituitary adenomas: a population based study in Malta","volume":"16","author":"Gruppetta","year":"2013","journal-title":"Pituitary"},{"key":"2026070713592928300_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/cen.13064","article-title":"Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study","volume":"85","author":"Gruppetta","year":"2016","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713592928300_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","article-title":"UK guidelines for the management of pituitary apoplexy","volume":"74","author":"Rajasekaran","year":"2011","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00701-004-0413-2","article-title":"Management of pituitary apoplexy: clinical experience with 40 patients","volume":"147","author":"Lubina","year":"2005","journal-title":"Acta Neurochirurgica"},{"key":"2026070713592928300_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1530\/EJE-10-0651","article-title":"Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome","volume":"164","author":"M\u00f6ller-Goede","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2026070713592928300_bib25","first-page":"25","article-title":"Pituitary apoplexy: clinical course, endocrine evaluations and treatment analysis","volume":"43","author":"da Motta","year":"1999","journal-title":"J Neurosurg Sci"},{"key":"2026070713592928300_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11102-005-1050-3","article-title":"Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases","volume":"7","author":"Sibal","year":"2004","journal-title":"Pituitary"},{"key":"2026070713592928300_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3171\/JNS\/2008\/108\/5\/0909","article-title":"Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results","volume":"108","author":"Semple","year":"2008","journal-title":"J Neurosurg"},{"key":"2026070713592928300_bib28","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1210\/clinem\/dgae649","article-title":"Pituitary apoplexy: comorbidities, management and outcomes \u2013 a Spanish observational multicenter study","volume":"110","author":"Biagetti","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070713592928300_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11102-020-01124-1","article-title":"Outcomes of pituitary apoplexy: a comparison of microadenomas and macroadenomas","volume":"24","author":"Nakhleh","year":"2021","journal-title":"Pituitary"},{"key":"2026070713592928300_bib30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/cen.12307","article-title":"Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom","volume":"80","author":"Bujawansa","year":"2014","journal-title":"Clin Endocrinol"},{"key":"2026070713592928300_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.wneu.2019.07.055","article-title":"Pituitary apoplexy: results of surgical and conservative management clinical series and review of the literature","volume":"130","author":"Almeida","year":"2019","journal-title":"World Neurosurg"},{"key":"2026070713592928300_bib32","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3171\/2020.9.JNS202899","article-title":"Radiological and clinical outcomes of pituitary apoplexy: comparison of conservative management versus early surgical intervention","volume":"135","author":"Shepard","year":"2021","journal-title":"J Neurosurg"},{"key":"2026070713592928300_bib33","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jocn.2009.11.012","article-title":"Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy","volume":"17","author":"Liu","year":"2010","journal-title":"J Clin Neurosci"},{"key":"2026070713592928300_bib34","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac113","article-title":"Revisiting pituitary apoplexy","volume":"6","author":"Donegan","year":"2022","journal-title":"J Endocr Soc"},{"key":"2026070713592928300_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/a-0640-2915","article-title":"Neuro-endocrine recovery after pituitary apoplexy: prolactin as a predictive factor","volume":"128","author":"Lammert","year":"2020","journal-title":"Exp Clin Endocrinol Diabetes"}],"container-title":["Endocrine Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eo.bioscientifica.com\/view\/journals\/eo\/5\/1\/EO-25-0008.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eo.bioscientifica.com\/downloadpdf\/journals\/eo\/5\/1\/EO-25-0008.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-25-0008\/506222\/eo-25-0008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-25-0008\/506222\/eo-25-0008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:59:40Z","timestamp":1783447180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article\/5\/1\/e250008\/75588\/Epidemiology-presentation-and-outcomes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eo-25-0008","relation":{},"ISSN":["2634-4793"],"issn-type":[{"value":"2634-4793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"e250008"}}